Summary
The relationship between vascular endothelial growth factor-C (VEGF-C)/vascular endothelial growth factor receptor 3 (VEGFR-3) expression and clinicopathologic features of the patients with non-small cell lung cancer (NSCLC) was investigated. The expression of VEGF-C and VEGFR-3 was assessed in 65 patients with NSCLC by immunohistochemistry. The significance of VEGF-C and VEGFR-3 expression was analyzed statistically. The results showed that VEGF-C and VEGFR-3 were highly expressed in cytoplasm and membrane in lung cancer tissues with the positive rate being 55.4 % and 52.3 % respectively, while there was no expression in the normal lung tissues. The expression of VEGF-C was significantly increased in a denocacinoma as compared to other types of NSCLC (P<0.05). The VEGFR-3 expression was closely related with lymph node metastasis (P<0.01) and TNM stage (P<0.05). There was a positive correlation between the VEGF-C and VEGFR-3 expression in NSCLC patients (r=0.658, P<0.01). It is suggested that VEGFR-3 plays an important role in the lymphatic metastasis of NSCLC. The interaction between VEGF-C and VEGFR-3 may be deeply involved in the mechanism of lung cancer metastasis.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Janne-marie B, Sylvse C, Marie-Christine C et al. Blood vessel and lymphatic vessel invasion in resected nonsmall cell lung carcinoma—correlation with TNM stage and disease free and overall survival. Cancer, 1996,78(10):2111–2118
Tsurusaki T, Kanda S, Sakai H et al. Vascular endothelial growth factor-C expression in human prostatic carcinoma and its relationship to lymph node metastasis. Br J Cancer, 1999,80(12):309–313
Che X M, Xu Y F, Wang K et al. Expression of VEGF and its relationship with lymph node metastasis in early gastric cancer. Chin J Gastrointest Surg (Chinese), 2002,12(5):285–287
Hoffman P C, Mauer A M, Vokes E E. Lung cancer. Lancet, 2000,355(9202): 479–485
Liu F. Vascular endothelial factor receptor 3. J Guangzhou Med College (Chinese), 2002,30(2):73–75
Kajita T, Ohta Y, Kimura K et al. The expression of vascular endothelial growth factor C and its receptors in non-small cell lung cancer. Br J Cancer, 2001, 85(2):255–260
Yonemura Y, Fushida S, Bando E et al. Lymphangiogenesis and the vascular endothelial growth factor receptor-3 in gastric cancer. Eur J Cancer, 2002, 37(7):918–923
Hashimoto I, Kodama J, Seki N et al. Vascular endothelial growth factor-C expression and its relationship to pelvic lymph node status in invasive cervical cancer. Br J Cancer, 2001,85(1):93–97
O-charoenrat P, Rhys-Evans P, Eccles S A. Expression of vascular endothelial growth factor family members in head and neck squamous cell carcinoma correlates with lymph node metastasis. Cancer, 2001,92(3):556–568
Niki T, Iba S, Yamada T et al. Expression of vascular endothelial growth factor receptor 3 in blood and lymphatic vessels of lung adenocarcinoma. J Pathol, 2001,193(4):450–457
Tanno S, Ohsaki Y, Nakanishi K et al. Human small cell lung cancer cells express functional VEGF receptors, VEGFR-2 and VEGFR-3. Lung Cancer, 2004, 46(1):11–19
Makinen T, Jussila L, Veikkola T et al. Inhibition of lymphangiogenesis with resulting lymphedema in transgenic mice expressing soluble VEGF receptor-3. Nat Med, 2001,7(2):199–20
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Li, J., Hong, M. & Pan, T. Clinical significance of VEGF-C and VEGFR-3 expression in non-small cell lung cancer. J. Huazhong Univ. Sc. Technol. 26, 587–590 (2006). https://doi.org/10.1007/s11596-006-0528-1
Received:
Issue Date:
DOI: https://doi.org/10.1007/s11596-006-0528-1